Inventor · disambiguated record
Margaretha Henrica Maria Bakker
Also filed as: BAKKER MARGARETHA · BAKKER MARGARETHA HENRICA MARI · BAKKER MARGARETHA HENRICA MARIA
23 granted patents·10 pending applications·82 citations·filing 2002–2019
93Inventor score
Files withABBVIE DEUTSCHLAND17JANSSEN PHARMACEUTICA NV4TURNER SEAN COLM4ABBOTT GMBH & CO KG2BRAJE WILFRIED2
Top patents by PatentIndex Score
33 records- 0188US9090592B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2011·Granted Jul 28, 2015·6 cites·29 claims
- 0288US8318793B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2010·Granted Nov 27, 2012·17 cites·19 claims
- 0387US10118926B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Nov 6, 2018·10 cites·6 claims
- 0486US9266855B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsTURNER SEAN COLM·Filed 2011·Granted Feb 23, 2016·11 cites·22 claims
- 0578US8664214B2Small molecule potentiators of metabotropic glutamate receptors IBRAJE WILFRIED·Filed 2011·Granted Mar 4, 2014·5 cites·19 claims
- 0677US9242933B2Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)GENESTE HERVE·Filed 2008·Granted Jan 26, 2016·3 cites·18 claims
- 0775US9169253B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2013·Granted Oct 27, 2015·1 cites·23 claims
- 0875US7491729B23-Substituted 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives, production and use thereofABBOTT GMBH & CO KG·Filed 2003·Granted Feb 17, 2009·9 cites·18 claims
- 0973US9573950B2Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulatorsABBVIE DEUTSCHLAND·Filed 2015·Granted Feb 21, 2017·2 cites·48 claims
- 1071US8455648B21-(7-(hexahydropyrrolo [3,4-c] pyrrol-2 (1H)-yl) quinolin-4-yl) -3- (pyrazin-2-yl) urea derivatives and related compounds as glycogen synthase kinase 3 (GSK-3)TURNER SEAN COLM·Filed 2009·Granted Jun 4, 2013·1 cites·19 claims
- 1171US8314120B2Small molecule potentiators of metabotropic glutamate receptorsBRAJE WILFRIED·Filed 2011·Granted Nov 20, 2012·2 cites·32 claims
- 1271US7501418B2Fused heterocyclic isoxazoline derivatives and their use as anti-depressantsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Mar 10, 2009·6 cites·7 claims
- 1367US7169786B2Isoxazoline derivatives as anti-depressantsANDRES-GIL JOSE IGNACIO·Filed 2002·Granted Jan 30, 2007·6 cites·16 claims
- 1465US7265103B2Substituted amino isoxazoline derivatives and their use as anti-depressantsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Sep 4, 2007·3 cites·12 claims
- 1564US2019048007A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1658US9994568B2Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2015·Granted Jun 12, 2018·0 cites·28 claims
- 1757US2020283439A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 1855US2019071443A1Tricyclic quinoline and quinoxaline derivativesABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 1954US9856234B2Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitorsABBVIE INC·Filed 2014·Granted Jan 2, 2018·0 cites·13 claims
- 2051US9540370B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 10, 2017·0 cites·28 claims
- 2150US8642598B2Heterocyclic compounds and their use as glycogen synthase kinase 3 inhibitorsTURNER SEAN C·Filed 2007·Granted Feb 4, 2014·0 cites·18 claims
- 2249US2017158693A1Hexahydrodiazepinoquinolines carrying a cyclic radicalABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 2349US2020002354A1Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disordersABBVIE DEUTSCHLAND·Filed 2019·Application pending·0 cites
- 2448US2017112851A1Hexahydrodiazepinoquinolines carrying a substituted alkyl radicalABBVIE DEUTSCHLAND·Filed 2017·Application pending·0 cites
- 2547US10100048B2Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsABBVIE DEUTSCHLAND·Filed 2015·Granted Oct 16, 2018·0 cites·25 claims
- 2647US2016194320A1Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitorsABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 2744US9540376B2Hexahydrodiazepinoquinolines carrying a substituted alkyl radicalABBVIE DEUTSCHLAND·Filed 2015·Granted Jan 10, 2017·0 cites·36 claims
- 2843US7994160B2Pyridazine compounds as glycogen synthase kinase 3 inhibitorsABBOTT GMBH & CO KG·Filed 2006·Granted Aug 9, 2011·0 cites·16 claims
- 2943US7462717B2C6-and C9-substituted chromeno[4,3-c]isoxazoline derivatives and their use as anti-depressantsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Dec 9, 2008·0 cites·11 claims
- 3042US7465741B2C-substituted tricyclic isoxazoline derivatives and their use as anti-depressantsJANSSEN PHARMACEUTICA NV·Filed 2003·Granted Dec 16, 2008·0 cites·8 claims
- 3141US2018339996A1Hexahydropyrazinobenz- or -pyrido-oxazepines carrying an oxygen-containing substituent and use thereof in the treatment of 5-ht2c-dependent disordersABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
- 3240US2020039930A1Proline amide compounds and their azetidine analogues carrying a specifically substituted benzyl radicalABBVIE DEUTSCHLAND·Filed 2018·Application pending·0 cites
- 3335US2019062305A1Pyridyl or pyrazinyl compounds carrying a methyl-bound alpha-amino acid amide groupABBVIE DEUTSCHLAND·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →